Literature DB >> 35584922

Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.

Gianina Toller1, Yann Cobigo2, Peter A Ljubenkov2, Brian S Appleby3, Bradford C Dickerson4, Kimiko Domoto-Reilly5, Jamie C Fong2, Leah K Forsberg6, Ralitza H Gavrilova6, Nupur Ghoshal7, Hilary W Heuer2, David S Knopman6, John Kornak8, Maria I Lapid9, Irene Litvan10, Diane E Lucente4, Ian R Mckenzie11, Scott M McGinnis4, Bruce L Miller2, Otto Pedraza12, Julio C Rojas2, Adam M Staffaroni2, Bonnie Wong4, Zbigniew K Wszolek13, Brad F Boeve6, Adam L Boxer2, Howard J Rosen2, Katherine P Rankin2.   

Abstract

BACKGROUND AND OBJECTIVES: Changes in social behavior are common symptoms of frontotemporal lobar degeneration (FTLD) and Alzheimer's disease syndromes. For early identification of individual patients and differential diagnosis, sensitive clinical measures are required that are able to assess patterns of behaviors and detect syndromic differences in both asymptomatic and symptomatic stages. We investigated whether the examiner-based Social Behavior Observer Checklist (SBOCL) is sensitive to early behavior changes and reflects disease severity within and between neurodegenerative syndromes.
METHODS: Asymptomatic individuals and neurodegenerative disease patients were selected from the multisite ALLFTD cohort study. In a sample of participants with at least one timepoint of SBOCL data, we investigated whether the Disorganized, Reactive, and Insensitive subscales of the SBOCL change as a function of disease stage within and between these syndromes. In a longitudinal subsample with both SBOCL and neuroimaging data, we examined whether change over time on each subscale corresponds to progressive gray matter atrophy.
RESULTS: 1082 FTLD mutation carriers and non-carriers were enrolled (282 asymptomatic, 341 behavioral variant frontotemporal dementia, 114 semantic and 95 non-fluent variant primary progressive aphasia, 137 progressive supranuclear palsy, 113 Alzheimer's clinical syndrome). The Disorganized score increased between asymptomatic to very mild (p=0.016, estimate=-1.10, 95%CI=[-1.99, -0.22]), very mild to mild (p=0.013, -1.17, [-2.08, -0.26]), and mild to moderate/severe (p<0.001, -2.00, [-2.55, -1.45]) disease stages in behavioral variant frontotemporal dementia regardless of mutation status. Asymptomatic GRN pathogenic gene variant carriers showed more Reactive behaviors (preoccupation with time: p=0.001, 1.11, [1.06, 1.16]; self-consciousness: p=0.003, 1.77, [1.52, 2.01]) than asymptomatic non-carriers (1.01, [0.98, 1.03]; 1.31, [1.20, 1.41]). Insensitive score increased to a clinically abnormal level in advanced stages of behavioral variant frontotemporal dementia (p=0.003, -0.73, [-1.18, -0.29]). Higher scores on each subscale corresponded with higher caregiver burden (p<0.001). Greater change over time corresponded to greater fronto-subcortical atrophy in the semantic-appraisal and fronto-parietal intrinsically connected networks. DISCUSSION: The SBOCL is sensitive to early symptoms and reflects disease severity, with some evidence for progression across asymptomatic and symptomatic stages of FTLD syndromes; thus it may hold promise for early measurement and monitoring of behavioral symptoms in clinical practice and treatment trials. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the Social Behavior Observer Checklist is sensitive to early behavioral changes in FTLD pathogenic variants and early symptomatic individuals in a highly educated patient cohort.
© 2022 American Academy of Neurology.

Entities:  

Keywords:  Social Behavior Observer Checklist; behavior; behavioral variant frontotemporal dementia; clinical trials; neurodegenerative disease; social cognition

Year:  2022        PMID: 35584922      PMCID: PMC9421596          DOI: 10.1212/WNL.0000000000200582

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   11.800


  47 in total

1.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

2.  Language and behavior domains enhance the value of the clinical dementia rating scale.

Authors:  David S Knopman; Sandra Weintraub; Vernon S Pankratz
Journal:  Alzheimers Dement       Date:  2011-05       Impact factor: 21.566

3.  Empathic Accuracy Deficits in Patients with Neurodegenerative Disease: Association with Caregiver Depression.

Authors:  Casey L Brown; Sandy J Lwi; Madeleine S Goodkind; Katherine P Rankin; Jennifer Merrilees; Bruce L Miller; Robert W Levenson
Journal:  Am J Geriatr Psychiatry       Date:  2017-12-27       Impact factor: 4.105

Review 4.  Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.

Authors:  I Litvan; Y Agid; C Goetz; J Jankovic; G K Wenning; J P Brandel; E C Lai; M Verny; K Ray-Chaudhuri; A McKee; K Jellinger; R K Pearce; J J Bartko
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

5.  Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers.

Authors:  Enrico Premi; Anna Formenti; Stefano Gazzina; Silvana Archetti; Roberto Gasparotti; Alessandro Padovani; Barbara Borroni
Journal:  JAMA Neurol       Date:  2014-02       Impact factor: 18.302

6.  The salience network causally influences default mode network activity during moral reasoning.

Authors:  Winston Chiong; Stephen M Wilson; Mark D'Esposito; Andrew S Kayser; Scott N Grossman; Pardis Poorzand; William W Seeley; Bruce L Miller; Katherine P Rankin
Journal:  Brain       Date:  2013-04-09       Impact factor: 13.501

7.  Observation of social behavior in frontotemporal dementia.

Authors:  Mario F Mendez; Sylvia S Fong; Jill S Shapira; Elvira E Jimenez; Natalie C Kaiser; Sarah A Kremen; Po-Heng Tsai
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12-26       Impact factor: 2.035

8.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Authors:  Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

9.  Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers.

Authors:  Suzee E Lee; Ana C Sias; Eena L Kosik; Taru M Flagan; Jersey Deng; Stephanie A Chu; Jesse A Brown; Anna A Vidovszky; Eliana Marisa Ramos; Maria Luisa Gorno-Tempini; Anna M Karydas; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; Bradley F Boeve; Adam L Boxer; Howard J Rosen; Bruce L Miller; William W Seeley
Journal:  Neuroimage Clin       Date:  2019-03-16       Impact factor: 4.881

Review 10.  The frontoparietal network: function, electrophysiology, and importance of individual precision mapping.

Authors:  Scott Marek; Nico U F Dosenbach
Journal:  Dialogues Clin Neurosci       Date:  2018-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.